Takeda Pharmaceutical Company Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was JPY 3,569,006 million compared to JPY 3,197,812 million a year ago. Net income was JPY 230,059 million compared to JPY 376,005 million a year ago. Basic earnings per share from continuing operations was JPY 147.14 compared to JPY 240.72 a year ago. Diluted earnings per share from continuing operations was JPY 145.87 compared to JPY 238.96 a year ago.